TRENDSPOTTER: Corporate Venture Capital May Rival Traditional VC Firms in -omic Funding | GenomeWeb

Today in Europe there is a growing trend toward establishing venture-capital funds that are sourced exclusively by a major corporation. 

Some big pharmaceutical firms have recognized the potential rewards for nurturing small start-up firms—namely, novel IP—and have begun putting together modest funds of their own to pursue them. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.